GlassScriptPhysician profile
Christopher Robert Pryor
NPI 1730569245
$2,261.84
in general payments reported to CMS, 2019-2025
13 companies · $129 in 2025
The $129 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $119 · 2020: $206 · 2021: $913 · 2022: $894 · 2025: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $128.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $567.83 | 2019-2022 | |
| Neurocrine Biosciences, INC. | $325.37 | 2020-2022 | |
| Lundbeck LLC | $265.31 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $240.56 | 2020-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $211.27 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $173.28 | 2022-2025 | |
| Sunovion Pharmaceuticals INC. | $143.89 | 2021-2022 | |
| Abbvie INC. | $111.42 | 2021-2022 | |
| Alkermes, INC. | $101.91 | 2020-2021 | |
| Vanda Pharmaceuticals INC. | $62.88 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $32.62 | 2021 | |
| Indivior INC. | $13.19 | 2022 | |
| Eisai INC. | $12.31 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Pryor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.